CHUANG'S CH. HD-,05/ BMG2122W1010 /
6/27/2024 8:02:35 AM | Chg. 0.0000 | Volume | Bid8:02:37 AM | Ask9:00:01 AM | High | Low |
---|---|---|---|---|---|---|
0.0100EUR | 0.00% | 0 Turnover: 0.0000 |
-Bid Size: - | -Ask Size: - | 0.0100 | 0.0100 |
GlobeNewswire
2:00 AM
ROSEN, THE FIRST FILING FIRM, Encourages FutureFuel Corp. Investors to Secure Counsel Before Importa...
GlobeNewswire
1:51 AM
ROSEN, LEADING INVESTOR COUNSEL, Encourages Gritstone bio, Inc. Investors to Secure Counsel Before I...
GlobeNewswire
1:39 AM
“LEQEMBI®” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched in China
GlobeNewswire
1:38 AM
Unlocking the Future of Trading with Spotrade.net: A Leader in AI Spot Signals
GlobeNewswire
1:31 AM
PATH INVESTOR ALERT: Edelson Lechtzin LLP Urges UiPath, Inc. (NYSE: PATH) Shareholders to Consult Le...
GlobeNewswire
1:30 AM
ROSEN, A LEADING LAW FIRM, Encourages Charge Enterprises, Inc. Investors to Secure Counsel Before Im...
GlobeNewswire
1:17 AM
TMCF President and CEO Dr. Harry L. Williams has released the following statement on the FY25 House ...
GlobeNewswire
1:15 AM
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Fastly, Inc. Investors to Secure Counsel Before Importan...
GlobeNewswire
1:10 AM
Ensho Therapeutics Launches with Phase 2-Ready Oral α4β7 Inhibitor for Inflammatory Bowel Disease
GlobeNewswire
1:00 AM
Worldwide License Agreement for EA1080, Oral Selective α4β7 Integrin Antagonist, Signed between EA P...
GlobeNewswire
12:30 AM
Renalytix Submits Hearing Request to Nasdaq Hearings Panel in Regard to Staff Delisting Determinatio...
GlobeNewswire
12:29 AM
Oxford Lane Capital Corp. Prices Public Offering of $100,000,000 8.75% Notes Due 2030